These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26473964)

  • 1. Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
    Knöös P; Svensson AV; Ulvenlund S; Wahlgren M
    PLoS One; 2015; 10(10):e0140709. PubMed ID: 26473964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral-based controlled release formulations using poly(acrylic acid) microgels.
    Wahlgren M; Christensen KL; Jørgensen EV; Svensson A; Ulvenlund S
    Drug Dev Ind Pharm; 2009 Aug; 35(8):922-9. PubMed ID: 19466881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using NMR chemical shift imaging to monitor swelling and molecular transport in drug-loaded tablets of hydrophobically modified poly(acrylic acid): methodology and effects of polymer (in)solubility.
    Knöös P; Topgaard D; Wahlgren M; Ulvenlund S; Piculell L
    Langmuir; 2013 Nov; 29(45):13898-908. PubMed ID: 24106807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of added surfactant on swelling and molecular transport in drug-loaded tablets based on hydrophobically modified poly(acrylic acid).
    Knöös P; Wahlgren M; Topgaard D; Ulvenlund S; Piculell L
    J Phys Chem B; 2014 Aug; 118(32):9757-67. PubMed ID: 25003981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid).
    Knöös P; Onder S; Pedersen L; Piculell L; Ulvenlund S; Wahlgren M
    Results Pharma Sci; 2013; 3():7-14. PubMed ID: 25755999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy.
    Pigliacelli C; Belton P; Wilde P; Qi S
    J Colloid Interface Sci; 2019 Sep; 551():147-154. PubMed ID: 31075629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers.
    Paulsson M; Edsman K
    J Colloid Interface Sci; 2002 Apr; 248(1):194-200. PubMed ID: 16290522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
    Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the release of lactose from polymer matrix tablets with an amperometric biosensor utilizing cellobiose dehydrogenase.
    Knöös P; Schulz C; Piculell L; Ludwig R; Gorton L; Wahlgren M
    Int J Pharm; 2014 Jul; 468(1-2):121-32. PubMed ID: 24726632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the drug release from ibuprofen matrix tablets with ethylcellulose and some poly-acrylate polymers.
    Tabandeh H; Mortazavi SA
    Pak J Pharm Sci; 2014 May; 27(3):495-503. PubMed ID: 24811808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
    Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
    Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method to screen for in-vivo performance of oral lipid formulations.
    Kilic M; Dressman J
    J Pharm Pharmacol; 2014 May; 66(5):615-23. PubMed ID: 24313318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of poly(ethylene oxide) in controlled release tablet systems: a review.
    Ma L; Deng L; Chen J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):845-51. PubMed ID: 24001212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Alvarez-Lorenzo C; Concheiro A
    Eur J Pharm Sci; 2005 Dec; 26(5):374-85. PubMed ID: 16165345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
    J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids.
    Persson EM; Gustafsson AS; Carlsson AS; Nilsson RG; Knutson L; Forsell P; Hanisch G; Lennernäs H; Abrahamsson B
    Pharm Res; 2005 Dec; 22(12):2141-51. PubMed ID: 16247711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.